News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
News|Articles|January 2, 2018

Risk Assessments and Sourcing Strategies for Excipients and APIs

Author(s)USP
Advertisement
External Link - PT1217 USP-Andruski F&C pr1f2-Web.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Advertisement

Related Content

Advertisement
Rezurock Treatment | Created with Canva

EMA Recommends Rezurock for Chronic Graft-Versus-Host Disease

ByZachary Zubulake
February 2nd 2026
FDA, Approved Food and Drug Administration concept. Quality, certification, health product standards control system. Businessman manages pharmaceutical quality documents. | Image Credit: ©Pakin -stock.adobe.com

FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing

BySusan Haigney
February 2nd 2026

Women in STEM: Inspiration from Innovators in Pharma

BySusan Haigney
February 2nd 2026
PharmTech Weekly News Roundup | Created with Canva

PharmTech Weekly News Roundup – Week of January 26, 2026

ByZachary Zubulake
January 30th 2026
Raj Puri, Argonaut Manufacturing

Navigating the Complex Risks of Accelerated Pharmaceutical Launches

BySusan Haigney
January 30th 2026
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility

2

PharmTech Weekly News Roundup – Week of January 26, 2026

3

Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases

4

FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing

5

Women in STEM: Inspiration from Innovators in Pharma

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us